Search

everythinglearnresearchcommunity

for

Search:↓

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

Saw palmetto extract can block the enzyme that converts testosterone in pig prostate cells.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Higher DHT in male baldness may protect against prostate cancer.

Minoxidil can increase hair density, speed up regrowth in transplanted hair, and slow down further hair loss, especially beneficial for women, young men with thinning hair, and those wanting to reconstruct the back of the scalp.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Finasteride reduces sperm count and quality and alters hormone levels in mice.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Minoxidil helps stabilize hair loss, increase density, and reduce shedding after hair transplant surgery.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Some skin diseases and their treatments can negatively affect male fertility.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Asparagus racemosus root extract reduced sebum and pore size in men but not in women.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Minoxidil with tretinoin boosts hair growth most effectively, followed by minoxidil alone, and then ketoconazole.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Topical cetirizine may help increase hair length in male pattern baldness and could be an alternative to minoxidil with fewer side effects.

Genetic factors could lead to personalized treatments for hair loss.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.